ANN ARBOR Nine hospitals in southeast Michigan have come together to form one of 25 regional stroke networks across the nation that will allow teams of researchers representing every medical specialty needed for stroke care to address the three prongs of stroke research: prevention, treatment and recovery. The new Michigan StrokeNet and its counterpart networks were announced Dec. 13 by the National Institutes of Health. It is the only network in Michigan, and will seek to add additional Michigan hospitals over time. Michigan StrokeNet will be coordinated by the University of Michigan Health Systems Stroke Program, and involves two U-M Health System hospitals, two from the Trinity Health system and five Detroit Medical Center hospitals. Dr. Philip Scott and Dr. Devin Brown of U-Ms Department of Emergency Medicine and Department of Neurology will serve as co-principal investigators. The new system is intended to streamline stroke research, by centralizing approval and review, lessening time and costs of clinical trials, and assembling a comprehensive data sharing system, said Dr. Petra Kaufmann, the associate director for clinical research at the National Institute of Neurological Disorders and Stroke (NINDS). NINDS, which will fund and manage the NIH Stroke Trials Network, or NIH StrokeNet, has … Continue reading →

PUBLIC RELEASE DATE: 25-Dec-2013 Contact: Nicole Davis ndavis@broadinstitute.org 617-714-7152 Broad Institute of MIT and Harvard Cambridge and Boston, MA; Los Angeles, CA; Mexico City, Mexico. Wed. December 25, 2013 An international team of researchers in Mexico and the United States has uncovered a new genetic clue that contributes to an increased risk of developing type 2 diabetes, particularly the elevated risk among Mexican and other Latin American populations. The team, known as the SIGMA (Slim Initiative in Genomic Medicine for the Americas) Type 2 Diabetes Consortium, performed the largest genetic study to date in Mexican and Mexican American populations, discovering a risk gene for type 2 diabetes that had gone undetected in previous efforts. People who carry the higher risk version of the gene are 25 percent more likely to have diabetes than those who do not, and people who inherited copies from both parents are 50 percent more likely to have diabetes. The higher risk form of the gene has been found in up to half of people who have recent Native American ancestry, including Latin Americans. The variant is found in about 20 percent of East Asians and is rare in populations from Europe and Africa. The elevated … Continue reading →

Stem Cell Therapy: Knee Pain, Regenerative Therapy Options When suffering from knee pain, Prolotherapy, Platelet Rich Plasma and Stem Cell Therapy offer new hope. Each treatment can help your knee to heal, where surg... By: StemCell ARTS … Continue reading →

Stem Cell Therapy: Knee Pain, Failed Knee Surgery Even if knee surgery is successful, you may still be suffering from pain. Learn how biologic regenerative treatments can help complete the healing cycle afte... By: StemCell ARTS … Continue reading →

Stem Cell Therapy: Achilles Tendonitis Understand how this debilitating condition affects runners, and how biologic regenerative treatments go beyond physical therapy and very severe surgical opti... By: StemCell ARTS … Continue reading →